14 June 2019 - - Dr. Laurent Fischer has joined US-based gene circuit company Senti Biosciences as an independent member of its board of directors, the company said.
Fischer is currently senior vice president and head of the liver therapeutic a...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 June 2019 - - US-based biopharmaceutical company Prelude Therapeutics has secured USD 60m in series B financing; taking its total investments to date to USD 95m, the company said.
The financing was co-led by Prelude's two existing insti...
The financing was co-led by Prelude's two existing insti...
14 June 2019 - - US-based biopharmaceutical company Pfizer Inc. (NYSE: PFE) has received positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to severely active rheumatoid arthritis, the company said.
Patients ...
Patients ...
14 June 2019 - - The US Food and Drug Administration has accepted US-based Genentech's supplemental Biologics License Application and granted Priority Review for the use of Rituxan (rituximab), in combination with glucocorticoids, for the t...
14 June 2019 - - US-based Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, has appointed Tariq Kassum, M.D., as president and chief executive office...
14 June 2019 - - The US Food and Drug Administration has approved its PD-L1 IHC 22C3 pharmDx assay for expanded use, US-based Agilent Technologies Inc. (NYSE: A) said.
The assay is now approved as an aid in identifying patients with head a...
The assay is now approved as an aid in identifying patients with head a...
14 June 2019 - - US-based biotechnology company Seattle Genetics, Inc. (NASDAQ: SGEN) is presenting data from its Adcetris (brentuximab vedotin) clinical development programme at the 24th Annual Congress of the European Hematology Associati...